Jose A. Casado
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Lentiviral-mediated panErbB CAR-T cell therapy against head and neck squamous cell carcinomas for patients with Fanconi anemia.
Journal: Molecular therapy. Oncology
Published: April 17, 2025
Prognostic significance of mutation type and chromosome fragility in Fanconi anemia.
Journal: American journal of hematology
Published: July 24, 2024
Improved collection of hematopoietic stem cells and progenitors from Fanconi anemia patients for gene therapy purposes.
Journal: Molecular therapy. Methods & clinical development
Published: February 21, 2021
Natural gene therapy by reverse mosaicism leads to improved hematology in Fanconi anemia patients.
Journal: American journal of hematology
Published: February 17, 2021
Upregulation of NKG2D ligands impairs hematopoietic stem cell function in Fanconi anemia.
Journal: The Journal of clinical investigation
Published: August 18, 2020
Optimised molecular genetic diagnostics of Fanconi anaemia by whole exome sequencing and functional studies.
Journal: Journal of medical genetics
Published: May 02, 2019
Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression.
Journal: Nature medicine
Published: June 15, 2018
Detectable clonal mosaicism in blood as a biomarker of cancer risk in Fanconi anemia.
Journal: Blood advances
Published: August 29, 2016
Last Updated: 09/26/2026